Preventive Vaccines Market Report 2026
Download Free Sample Buy Now
Preventive Vaccines Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Preventive Vaccines Market Report 2026

Global Outlook – By Type (Live Or Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vector Vaccines), By Disease Type (Pneumococcal, Poliovirus, Hepatitis, Influenza, Measles, Rubella, Other Disease Types), By Age Group (Pediatric, Adult, Geriatric), By Distribution Channel (Hospitals, Clinics, Pharmacies, Other Distribution Channels) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Preventive Vaccines Market Overview

• Preventive Vaccines market size has reached to $83 billion in 2025

• Expected to grow to $131.27 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%

• Growth Driver: Surge In Infectious Diseases Fueling The Growth Of The Market Due To Rising Disease Prevalence And Urgent Need For Effective Control

• Market Trend: Advancements In Vaccine Technology Drive Enhanced Protection For High-risk Populations

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Preventive Vaccines Market?

Preventive vaccines are biological preparations designed to protect individuals from infectious diseases by stimulating the immune system to recognize and fight specific pathogens. They are administered before exposure to a disease-causing agent to prevent infection or reduce its severity. Preventive vaccines play a crucial role in public health by controlling the spread of contagious diseases.

The main types of preventive vaccines include live or attenuated vaccines, inactivated vaccines, toxoid vaccines, subunit vaccines, conjugate vaccines, DNA vaccines, and recombinant vector vaccines. Live or attenuated vaccines refer to vaccines made from weakened forms of the virus or bacteria that stimulate a strong and lasting immune response without causing disease. The disease types include pneumococcal, poliovirus, hepatitis, influenza, measles, rubella, and others, with distribution channels including hospitals, clinics, pharmacies, and other healthcare outlets. The age groups covered are pediatric, adult, and geriatric.

Preventive Vaccines Market Global Report 2026 Market Report bar graph

What Is The Preventive Vaccines Market Size and Share 2026?

The preventive vaccines market size has grown strongly in recent years. It will grow from $83 billion in 2025 to $90.33 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to eradication and control of infectious diseases, government-led vaccination initiatives, rising public health awareness, establishment of global immunization programs, increased funding from international health organizations.

What Is The Preventive Vaccines Market Growth Forecast?

The preventive vaccines market size is expected to see strong growth in the next few years. It will grow to $131.27 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to development of next-generation vaccine platforms, rising global population and urbanization, increasing outbreak preparedness initiatives, expansion of adult immunization programs, growth in public–private partnerships in vaccine development. Major trends in the forecast period include expansion of national immunization programs, rising focus on preventive healthcare and disease control, increasing demand for pediatric and geriatric vaccination, growth in combination and multivalent vaccines, strengthening cold chain and vaccine storage infrastructure.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Preventive Vaccines Market Segmentation

1) By Type: Live Or Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vector Vaccines

2) By Disease Type: Pneumococcal, Poliovirus, Hepatitis, Influenza, Measles, Rubella, Other Disease Types

3) By Age Group: Pediatric, Adult, Geriatric

4) By Distribution Channel: Hospitals, Clinics, Pharmacies, Other Distribution Channels

Subsegments:

1) By Live or Attenuated Vaccines: Measles, Mumps, and Rubella (MMR) Vaccine, Varicella (Chickenpox) Vaccine, Oral Polio Vaccine (OPV), Yellow Fever Vaccine, Rotavirus Vaccine, Bacillus Calmette-Guérin (BCG) Vaccine

2) By Inactivated Vaccines: Inactivated Poliovirus Vaccine (IPV), Hepatitis A Vaccine, Rabies Vaccine, Influenza (Inactivated) Vaccine, Japanese Encephalitis Vaccine

3) By Toxoid Vaccines: Tetanus Toxoid Vaccine, Diphtheria Toxoid Vaccine, Pertussis (whooping cough) Vaccine

4) By Subunit Vaccines: Hepatitis B Vaccine, Human Papillomavirus (HPV) Vaccine, Pertussis (acellular) Vaccine, Influenza (recombinant protein) Vaccine

5) By Conjugate Vaccines: Pneumococcal Conjugate Vaccine (PCV), Haemophilus influenzae type b (Hib) Vaccine, Meningococcal Conjugate Vaccine

6) By DNA Vaccines: Zika Virus DNA Vaccine, Cytomegalovirus (CMV) DNA Vaccine, Infectious Disease DNA Vaccines

7) By Recombinant Vector Vaccines: Ebola Vaccine (rVSV-ZEBOV), COVID-19 Recombinant Vector Vaccines, Dengue Recombinant Vector Vaccines

What Is The Driver Of The Preventive Vaccines Market?

The increasing prevalence of infectious diseases is expected to propel the growth of the preventive vaccines market going forward. Infectious diseases refer to illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites that can be transmitted from person to person or through the environment. The rise in prevalence of infectious diseases is driven by factors such as increasing urbanization, global travel, and antimicrobial resistance, which facilitate faster spread and harder control of infections. Preventive vaccines help control infectious diseases by stimulating the immune system to recognize and fight pathogens before infection occurs, thereby reducing disease incidence and transmission. For instance, in 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that the number of newly diagnosed TB (tuberculosis) cases worldwide reached 8.2 million in 2023, an increase from 7.5 million in 2022. Therefore, the increasing prevalence of infectious diseases is driving the growth of the preventive vaccines industry.

Key Players In The Global Preventive Vaccines Market

Major companies operating in the preventive vaccines market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Sanofi Pasteur SA, AstraZeneca plc, GlaxoSmithKline plc (GSK), Takeda Pharmaceutical Company Limited, Moderna Inc., CSL Limited, Novavax Inc., Emergent BioSolutions Inc., Dynavax Technologies Corporation, Serum Institute of India Pvt. Ltd., Vaxcyte Inc., Bavarian Nordic A/S, Valneva SE, Panacea Biotec Ltd., Inovio Pharmaceuticals Inc., Mitsubishi Tanabe Pharma Corporation, Afrigen Biologics and Vaccines (Pty) Ltd.

Global Preventive Vaccines Market Trends and Insights

Major companies operating in the preventive vaccines market are focusing on advancements in vaccine technology, such as advanced mRNA technology platforms, to enhance vaccine efficacy, improve safety profiles, enable faster development and manufacturing, and provide broader protection against emerging variants of infectious diseases. Advanced mRNA technology platforms refer to cutting-edge methods that use messenger RNA to instruct cells to produce specific proteins, triggering a targeted immune response. For instance, in March 2025, Moderna Inc., a US-based biotechnology company, announced FDA approval for mRNA-1283 (mNEXSPIKE), a new COVID-19 vaccine. It is authorized for adults aged 65 and older and individuals aged 12–64 with one or more CDC-defined risk factors. The launch of mNEXSPIKE marks a significant advancement in next-generation mRNA vaccine technology, offering improved stability and ease of storage compared to earlier versions. This development is expected to enhance vaccine accessibility and distribution, particularly in underserved and remote areas.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Preventive Vaccines Market?

In April 2024, European LifeCare Group, a UK-based vaccination company, acquired PreventVaccins B.V. for an undisclosed amount. Through this acquisition, European LifeCare Group expanded its European footprint and vaccination services through the acquisition of PreventVaccins B.V., enhancing its presence in the Dutch market. PreventVaccins B.V. is a Netherlands-based biotechnology company that focuses on the development of preventive vaccines, especially for infectious diseases.

Regional Insights

North America was the largest region in the preventive vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Preventive Vaccines Market?

The preventive vaccines market consists of sales of toxoid vaccines, plant-based vaccines, and combination vaccines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Preventive Vaccines Market Report 2026?

The preventive vaccines market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the preventive vaccines industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Preventive Vaccines Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $90.33 billion
Revenue Forecast In 2035 $131.27 billion
Growth Rate CAGR of 8.8% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Disease Type, Age Group, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Sanofi Pasteur SA, AstraZeneca plc, GlaxoSmithKline plc (GSK), Takeda Pharmaceutical Company Limited, Moderna Inc., CSL Limited, Novavax Inc., Emergent BioSolutions Inc., Dynavax Te
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Preventive Vaccines Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Preventive Vaccines Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Preventive Vaccines Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Preventive Vaccines Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Expansion Of National Immunization Programs

4.2.2 Rising Focus On Preventive Healthcare And Disease Control

4.2.3 Increasing Demand For Pediatric And Geriatric Vaccination

4.2.4 Growth In Combination And Multivalent Vaccines

4.2.5 Strengthening Cold Chain And Vaccine Storage Infrastructure

5. Preventive Vaccines Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Public Health Organizations

5.4 Vaccination Centers

5.5 Pharmacies

6. Preventive Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Preventive Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Preventive Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Preventive Vaccines Market Size, Comparisons And Growth Rate Analysis

7.3. Global Preventive Vaccines Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Preventive Vaccines Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Preventive Vaccines Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Preventive Vaccines Market Segmentation

9.1. Global Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Live Or Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vector Vaccines

9.2. Global Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pneumococcal, Poliovirus, Hepatitis, Influenza, Measles, Rubella, Other Disease Types

9.3. Global Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pediatric, Adult, Geriatric

9.4. Global Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Pharmacies, Other Distribution Channels

9.5. Global Preventive Vaccines Market, Sub-Segmentation Of Live Or Attenuated Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Measles, Mumps, and Rubella (MMR) Vaccine, Varicella (Chickenpox) Vaccine, Oral Polio Vaccine (OPV), Yellow Fever Vaccine, Rotavirus Vaccine, Bacillus Calmette-Guérin (BCG) Vaccine

9.6. Global Preventive Vaccines Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Inactivated Poliovirus Vaccine (IPV), Hepatitis A Vaccine, Rabies Vaccine, Influenza (Inactivated) Vaccine, Japanese Encephalitis Vaccine

9.7. Global Preventive Vaccines Market, Sub-Segmentation Of Toxoid Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tetanus Toxoid Vaccine, Diphtheria Toxoid Vaccine, Pertussis (whooping cough) Vaccine

9.8. Global Preventive Vaccines Market, Sub-Segmentation Of Subunit Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hepatitis B Vaccine, Human Papillomavirus (HPV) Vaccine, Pertussis (acellular) Vaccine, Influenza (recombinant protein) Vaccine

9.9. Global Preventive Vaccines Market, Sub-Segmentation Of Conjugate Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pneumococcal Conjugate Vaccine (PCV), Haemophilus influenzae type b (Hib) Vaccine, Meningococcal Conjugate Vaccine

9.10. Global Preventive Vaccines Market, Sub-Segmentation Of DNA Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Zika Virus DNA Vaccine, Cytomegalovirus (CMV) DNA Vaccine, Infectious Disease DNA Vaccines

9.11. Global Preventive Vaccines Market, Sub-Segmentation Of Recombinant Vector Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ebola Vaccine (rVSV-ZEBOV), COVID-19 Recombinant Vector Vaccines, Dengue Recombinant Vector Vaccines

10. Preventive Vaccines Market Regional And Country Analysis

10.1. Global Preventive Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Preventive Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Preventive Vaccines Market

11.1. Asia-Pacific Preventive Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Preventive Vaccines Market

12.1. China Preventive Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Preventive Vaccines Market

13.1. India Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Preventive Vaccines Market

14.1. Japan Preventive Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Preventive Vaccines Market

15.1. Australia Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Preventive Vaccines Market

16.1. Indonesia Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Preventive Vaccines Market

17.1. South Korea Preventive Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Preventive Vaccines Market

18.1. Taiwan Preventive Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Preventive Vaccines Market

19.1. South East Asia Preventive Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Preventive Vaccines Market

20.1. Western Europe Preventive Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Preventive Vaccines Market

21.1. UK Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Preventive Vaccines Market

22.1. Germany Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Preventive Vaccines Market

23.1. France Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Preventive Vaccines Market

24.1. Italy Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Preventive Vaccines Market

25.1. Spain Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Preventive Vaccines Market

26.1. Eastern Europe Preventive Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Preventive Vaccines Market

27.1. Russia Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Preventive Vaccines Market

28.1. North America Preventive Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Preventive Vaccines Market

29.1. USA Preventive Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Preventive Vaccines Market

30.1. Canada Preventive Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Preventive Vaccines Market

31.1. South America Preventive Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Preventive Vaccines Market

32.1. Brazil Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Preventive Vaccines Market

33.1. Middle East Preventive Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Preventive Vaccines Market

34.1. Africa Preventive Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Preventive Vaccines Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Preventive Vaccines Market Regulatory and Investment Landscape

36. Preventive Vaccines Market Competitive Landscape And Company Profiles

36.1. Preventive Vaccines Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Preventive Vaccines Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Preventive Vaccines Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sanofi Pasteur SA Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

37. Preventive Vaccines Market Other Major And Innovative Companies

GlaxoSmithKline plc (GSK), Takeda Pharmaceutical Company Limited, Moderna Inc., CSL Limited, Novavax Inc., Emergent BioSolutions Inc., Dynavax Technologies Corporation, Serum Institute of India Pvt. Ltd., Vaxcyte Inc., Bavarian Nordic A/S, Valneva SE, Panacea Biotec Ltd., Inovio Pharmaceuticals Inc., Mitsubishi Tanabe Pharma Corporation, Afrigen Biologics and Vaccines (Pty) Ltd.

38. Global Preventive Vaccines Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Preventive Vaccines Market

40. Preventive Vaccines Market High Potential Countries, Segments and Strategies

40.1 Preventive Vaccines Market In 2030 - Countries Offering Most New Opportunities

40.2 Preventive Vaccines Market In 2030 - Segments Offering Most New Opportunities

40.3 Preventive Vaccines Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Preventive Vaccines Market, Overview Of Key Products - Product Examples
  • Table 2: Global Preventive Vaccines Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Preventive Vaccines Market, Supply Chain Analysis
  • Table 4: Global Preventive Vaccines Market, Major Raw Material Providers
  • Table 5: Global Preventive Vaccines Market, Major Resource Providers
  • Table 6: Global Preventive Vaccines Market, Major Manufacturers (Suppliers)
  • Table 7: Global Preventive Vaccines Market, Major Distributors And Channel Partners
  • Table 8: Global Preventive Vaccines Market, Key Technologies & Future Trends
  • Table 9: Global Preventive Vaccines Market, Major Trends
  • Table 10: Global Preventive Vaccines Market, Major End Users
  • Table 11: Global Preventive Vaccines Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Preventive Vaccines Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Preventive Vaccines Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Preventive Vaccines Market - TAM, US$ Billion, 2025
  • Table 15: Global Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Preventive Vaccines Market, Sub-Segmentation Of Live Or Attenuated Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Preventive Vaccines Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Preventive Vaccines Market, Sub-Segmentation Of Toxoid Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Preventive Vaccines Market, Sub-Segmentation Of Subunit Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Preventive Vaccines Market, Sub-Segmentation Of Conjugate Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Preventive Vaccines Market, Sub-Segmentation Of DNA Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Preventive Vaccines Market, Sub-Segmentation Of Recombinant Vector Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Global Preventive Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Global Preventive Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Asia-Pacific, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Asia-Pacific, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: China, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: China, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: India, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: India, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Japan, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Japan, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Australia, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Australia, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Indonesia, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Indonesia, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South Korea, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South Korea, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Taiwan, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Taiwan, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: South East Asia, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: South East Asia, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Western Europe, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Western Europe, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: UK, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: UK, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Germany, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Germany, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: France, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: France, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Italy, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Italy, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Spain, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Spain, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Eastern Europe, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Eastern Europe, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Russia, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: Russia, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: North America, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: North America, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: USA, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: USA, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Canada, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Canada, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: South America, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: South America, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Brazil, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Brazil, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Middle East, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Middle East, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Africa, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Africa, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 100: Global Preventive Vaccines Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 101: Global Preventive Vaccines Market - Company Scoring Matrix
  • Table 102: Pfizer Inc. Financial Performance
  • Table 103: Johnson & Johnson Services Inc. Financial Performance
  • Table 104: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 105: Sanofi Pasteur SA Financial Performance
  • Table 106: AstraZeneca plc Financial Performance
  • Table 107: Global Preventive Vaccines Market, Competitive Benchmarking (In USD Billions)
  • Table 108: Global Preventive Vaccines Market, Competitive Dashboard
  • Table 109: Global Preventive Vaccines Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 110: Global, Preventive Vaccines Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 111: Global, Preventive Vaccines Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030
  • Table 112: Global, Preventive Vaccines Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

List Of Figures

    Figure 1: Global Preventive Vaccines Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Preventive Vaccines Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Preventive Vaccines Market, Supply Chain Analysis
  • Figure 4: Global Preventive Vaccines Market, Major Raw Material Providers
  • Figure 5: Global Preventive Vaccines Market, Major Resource Providers
  • Figure 6: Global Preventive Vaccines Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Preventive Vaccines Market, Major Distributors And Channel Partners
  • Figure 8: Global Preventive Vaccines Market, Key Technologies & Future Trends
  • Figure 9: Global Preventive Vaccines Market, Major Trends
  • Figure 10: Global Preventive Vaccines Market, Major End Users
  • Figure 11: Global Preventive Vaccines Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Preventive Vaccines Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Preventive Vaccines Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Preventive Vaccines Market - TAM, US$ Billion, 2025
  • Figure 15: Global Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Preventive Vaccines Market, Sub-Segmentation Of Live Or Attenuated Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Preventive Vaccines Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Preventive Vaccines Market, Sub-Segmentation Of Toxoid Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Preventive Vaccines Market, Sub-Segmentation Of Subunit Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Preventive Vaccines Market, Sub-Segmentation Of Conjugate Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Preventive Vaccines Market, Sub-Segmentation Of DNA Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Preventive Vaccines Market, Sub-Segmentation Of Recombinant Vector Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Global Preventive Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Global Preventive Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Asia-Pacific, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Asia-Pacific, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: China, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: China, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: India, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: India, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Japan, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Japan, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Australia, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Australia, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Indonesia, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Indonesia, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South Korea, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South Korea, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Taiwan, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Taiwan, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: South East Asia, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: South East Asia, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Western Europe, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Western Europe, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: UK, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: UK, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Germany, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Germany, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: France, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: France, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Italy, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Italy, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Spain, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Spain, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Eastern Europe, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Eastern Europe, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Russia, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: Russia, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: North America, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: North America, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: USA, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: USA, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Canada, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Canada, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: South America, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: South America, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Brazil, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Brazil, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Middle East, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Middle East, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Africa, Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Africa, Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 100: Global Preventive Vaccines Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 101: Global Preventive Vaccines Market - Company Scoring Matrix
  • Figure 102: Pfizer Inc. Financial Performance
  • Figure 103: Johnson & Johnson Services Inc. Financial Performance
  • Figure 104: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 105: Sanofi Pasteur SA Financial Performance
  • Figure 106: AstraZeneca plc Financial Performance
  • Figure 107: Global Preventive Vaccines Market, Competitive Benchmarking (In USD Billions)
  • Figure 108: Global Preventive Vaccines Market, Competitive Dashboard
  • Figure 109: Global Preventive Vaccines Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 110: Global, Preventive Vaccines Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 111: Global, Preventive Vaccines Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030
  • Figure 112: Global, Preventive Vaccines Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Adult Vaccines Market Report 2026 - Global Outlook – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Con...

Therapeutic BCG Vaccines Market Report 2026 - Global Outlook – By Type (Therapy BCG, Other Types), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users) - Market Size, Trends, And Global ...

Travel Vaccines Market Report 2026 - Global Outlook – By Disease (Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,), By ...

Influenza Vaccines Market Report 2026 - Global Outlook – By Vaccine Type (Inactivated, Live Attenuated), By Valency (Quadrivalent, Trivalent), By Route Of Administration (Injection, Nasal Spray), By Age Group (Pediatric,...

Plant-Based Vaccines Market Report 2026 - Global Outlook – By Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types), By Source (Tobacco Plant, Maize, Potato, Other Sources), By Applica...

Inactivated Vaccines Market Report 2026 - Global Outlook – By Type (Viral Vaccine, Bacterial Vaccine), By Method Of Inactivation (Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inacti...

Malaria Vaccines Market Report 2026 - Global Outlook – By Agent (Plasmodium Falciparum, Plasmodium Vivax), By Vaccine Type (Pre-Erythrocytic, Erythrocytic, Multi-antigen, Other Vaccines), By Route Of Administration (Intr...

Cancer Vaccines Market Report 2026 - Global Outlook – By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines ), By Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant...

Frequently Asked Questions

The Preventive Vaccines Market Report 2026 market was valued at $83 billion in 2025, increased to $90.33 billion in 2026, and is projected to reach $131.27 billion by 2030. request a sample here

The expected CAGR for the Preventive Vaccines Market Report 2026 market during the forecast period 2025–2030 is 9.8%. request a sample here

Major growth driver of the market includes: Surge In Infectious Diseases Fueling The Growth Of The Market Due To Rising Disease Prevalence And Urgent Need For Effective Control in the Preventive Vaccines Market Report 2026 market. For further insights on this market, request a sample here

The preventive vaccines market covered in this report is segmented –
1) By Type: Live Or Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vector Vaccines
2) By Disease Type: Pneumococcal, Poliovirus, Hepatitis, Influenza, Measles, Rubella, Other Disease Types
3) By Age Group: Pediatric, Adult, Geriatric
4) By Distribution Channel: Hospitals, Clinics, Pharmacies, Other Distribution Channels Subsegments:
1) By Live or Attenuated Vaccines: Measles, Mumps, and Rubella (MMR) Vaccine, Varicella (Chickenpox) Vaccine, Oral Polio Vaccine (OPV), Yellow Fever Vaccine, Rotavirus Vaccine, Bacillus Calmette-Guérin (BCG) Vaccine
2) By Inactivated Vaccines: Inactivated Poliovirus Vaccine (IPV), Hepatitis A Vaccine, Rabies Vaccine, Influenza (Inactivated) Vaccine, Japanese Encephalitis Vaccine
3) By Toxoid Vaccines: Tetanus Toxoid Vaccine, Diphtheria Toxoid Vaccine, Pertussis (whooping cough) Vaccine
4) By Subunit Vaccines: Hepatitis B Vaccine, Human Papillomavirus (HPV) Vaccine, Pertussis (acellular) Vaccine, Influenza (recombinant protein) Vaccine
5) By Conjugate Vaccines: Pneumococcal Conjugate Vaccine (PCV), Haemophilus influenzae type b (Hib) Vaccine, Meningococcal Conjugate Vaccine
6) By DNA Vaccines: Zika Virus DNA Vaccine, Cytomegalovirus (CMV) DNA Vaccine, Infectious Disease DNA Vaccines
7) By Recombinant Vector Vaccines: Ebola Vaccine (rVSV-ZEBOV), COVID-19 Recombinant Vector Vaccines, Dengue Recombinant Vector Vaccines request a sample here

Major trend in this market includes: Advancements In Vaccine Technology Drive Enhanced Protection For High-risk Populations For further insights on this market, request a sample here.

Major companies operating in the Preventive Vaccines Market Report 2026 market are Major companies operating in the preventive vaccines market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Sanofi Pasteur SA, AstraZeneca p request a sample here.

North America was the largest region in the preventive vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the preventive vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us